🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

17 recruiting trials

for Medullary Thyroid Cancer

Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC NCT07138716NA1 site📍 Beijing Luo Yaping · Tests: 68Ga-DOTA-CCK-FS PET/CT 68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC NCT06277180NA1 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Surgery, Surgery Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites📍 Iowa City📍 Boston📍 Royal Oak Novartis Pharmaceuticals · Tests: 225Ac-ETN029, 111In-ETN029 Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001) NCT06141369NA1 site📍 Shanghai Shanghai Jiao Tong University School of Medicine · Tests: individualized mRNA neoantigen vaccine (mRNA-0523-L001) Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers NCT03892993NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Decision Aid, Questionnaire Administration Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... NCT06161532Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Sacituzumab govitecan, Atezolizumab Phase II Trial of Sacituzumab Tirumotecan in Patients With SMARCB1-Deficient Renal Medullary Carcinoma NCT07438626Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Sacituzumab tirumotecan Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management NCT04216732n/a2 sites📍 San Francisco📍 Houston M.D. Anderson Cancer Center · Tests: Blood Pressure Measurement, Questionnaire Administration Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors NCT03866382Phase 2582 sites📍 Birmingham📍 Anchorage📍 Anchorage National Cancer Institute (NCI) · Tests: Biospecimen Collection, Bone Scan, Cabozantinib S-malate, Computed Tomography, Echocardiography Test Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma NCT06302569Phase 21 site📍 Milan Giuseppe Procopio · Tests: Pembrolizumab + Enfortumab Vedotin Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients NCT06523582n/a3 sites📍 Mexico City📍 Mexico City📍 Mexico City Universidad Nacional Autonoma de Mexico CTR-FAPI-guided Precision Surgery for Newly Diagnosed MTC NCT07383246Phase 31 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: 68Ga-CTR-FAPI PET-CT guided surgery, investigator choice of surgery Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer NCT01109420n/a1 site📍 Bethesda National Institute of Diabetes and Digestive and Kidney Dis… Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496Phase 1, Phase 23 sites📍 Gilbert📍 Tucson📍 Seattle University of Arizona · Tests: Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma NCT05830500Phase 419 sites📍 Hefei📍 Beijing📍 Lanzhou Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Tests: Anlotinib Hydrochloride Capsule Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer NCT07142005n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Interviews GETNE Registration of Thyroid Cancer NCT03765333n/a1 site📍 Barcelona Grupo Espanol de Tumores Neuroendocrinos
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy